HomeAPIImatinib Mesylate (IP)

Imatinib Mesylate (IP)

Enquire Now

Product CAS No


Product Description

Imatinib mesylate belongs to the signal transduction inhibitor category of targeted therapies. It is particularly a protein-tyrosine kinase inhibitor.

Therapeutic Action

Imatinib is used to treat certain types of cancer (such as acute lymphoblastic leukemia, chronic myeloid leukemia, gastrointestinal stromal tumors, and myelodysplastic/myeloproliferative diseases).

Enquire Now
close slider